C2H2 zinc fingers are found in several key transcriptional regulators in the immune system. However, these proteins usually contain more fingers than are needed for sequence-specific DNA binding, which suggests that different fingers regulate different genes and functions. Here we found that mice lacking finger 1 or finger 4 of Ikaros exhibited distinct subsets of the hematological defects of Ikaros-null mice. Most notably, the two fingers controlled different stages of lymphopoiesis, and finger 4 was selectively required for tumor suppression. The distinct defects support the hypothesis that only a small number of genes that are targets of Ikaros are critical for each of its biological functions. The subcategorization of functions and target genes by mutagenesis of individual zinc fingers will facilitate efforts to understand how zinc-finger transcription factors regulate development, immunity and disease.
In the post-genomics era, a critical goal is to define the target genes and mechanisms of action of transcription factors that contribute to the development of multicellular organisms, disease and the response to environmental cues. Although progress in this area has been rapid, a major hurdle is that many factors are involved in several biological pathways and can contribute to multiple steps in a single pathway, which makes it difficult to study key regulatory events in isolation. Ikaros is one transcription factor that regulates numerous biological events. Ikaros-null (Ikzf1 null ) mice lack B lineage cells, natural killer cells, peripheral lymph nodes and fetal T cells, and they exhibit many other abnormalities [1] [2] [3] . B cells are absent from adult Ikzf1 null mice because of an inability of lymphoid-primed multipotent progenitor cells to develop into common lymphoid progenitor cells 4 , but Ikaros also regulates later stages of B cell development [5] [6] [7] [8] [9] . Moreover, mice with mutations in the gene encoding Ikaros (Ikzf1) develop thymic lymphoma with high penetrance 10, 11 .
In humans, mutations at the IKZF1 locus have been observed in a high percentage of samples of BCR-ABL + B cell acute lymphoblastic leukemia (B-ALL) and high-risk progenitor B-ALL 12, 13 . IKZF1 was the only gene for which mutations were found to be useful in predicting a poor response to therapy 13 , yet the mechanisms responsible for tumor suppression by Ikaros remain poorly understood. Ikaros is thought to contribute to both the activation and repression of transcription, with the Mi-2-NuRD complex as a predominant interacting partner [14] [15] [16] . Notably, the target genes responsible for most of the key phenotypes of Ikaros-mutant mice remain unknown 7, [17] [18] [19] . The widespread deregulation of gene expression in Ikaros-mutant cells and the finding that Ikaros binds several thousand genomic sites have increased the challenge of identifying the mechanisms by which Ikaros regulates lymphocyte development and leukemogenesis 16, 20 .
Members of the Ikaros family have a conserved DNA-binding domain near the amino (N) terminus, usually with four C2H2 zinc fingers 21 . Ikaros proteins also have two carboxy (C)-terminal C2H2 zinc fingers dedicated to dimerization and multimerization [22] [23] [24] . C2H2 zinc fingers are found in many ubiquitous transcription factors and in numerous proteins involved in tissue-specific and developmental stage-specific transcription [25] [26] [27] , including PLZF, Bcl-6, Gfi1, Blimp-1 and ThPOK of the immune system.
Stable binding of DNA in vitro by a C2H2 zinc-finger protein usually requires two or three tandem fingers 27, 28 . In Ikaros, fingers 2 and 3 are sufficient for stable binding and recognize the core consensus sequence GGGAA. In contrast, fingers 1 and 4 seem to modulate binding to specific sites [29] [30] [31] . In addition to expressing full-length Ikaros (Ik-1), most or all hematopoietic cells have abundant expression of a smaller isoform that lacks finger 1 (Ik-2). Ikaros isoforms that lack other fingers because of alternative splicing of pre-mRNA have been observed, but these isoforms are generally much less abundant except in transformed cell lines 29, 32, 33 . 1 0 7 4 VOLUME 14 NUMBER 10 OCTOBER 2013 nature immunology A r t i c l e s Given that two or three fingers are generally sufficient for stable binding of DNA 28 , it is striking that most zinc-finger DNA-binding proteins contain more than three tandem fingers. The reasons for this phenomenon have been of interest since the early studies of the nine-finger protein TFIIIA 27, 34, 35 . All of the tandem fingers may be required for stable binding to key targets in vivo, with the multiple fingers recognizing extended DNA regions with high specificity. Alternatively, defined subsets of fingers may recognize distinct target genes. Initial support for the latter hypothesis emerged from in vitro protein-DNA-interaction studies showing that different combinations of fingers from TFIIIA, Ikaros, CTCF and other proteins can bind different DNA sequences 29, 30, [35] [36] [37] [38] [39] . In addition, studies of ectopically expressed mutant CTCF by chromatin immunoprecipitation followed by deep sequencing (ChIP-seq) have revealed that CTCF-binding sites can be separated into distinct classes on the basis of binding by different finger subsets 40 .
To determine in a physiological setting whether multifinger DNA-binding proteins use different fingers to regulate different genes and biological functions, or whether all functions require the full complement of fingers, we generated two new Ikaros-mutant mouse strains with germline deletion of Ikzf1 exons encoding fingers 1 and 4. Phenotypic analysis suggested that the two fingers regulate distinct biological events. Transcriptome profiling confirmed that the two fingers regulate distinct sets of genes, and DNA-binding analyses confirmed that fingers 1 and 4 can modulate binding to different genomic sites. Finally, in vitro and in vivo models of BCR-ABL + B-ALL established parallels between tumor suppression in thymocytes and that in B-ALL. Together these results suggest that multifinger DNA-binding domains exist at least in part to allow different fingers to regulate different genes. Moreover, the notably different phenotypes of the mutant strains suggest that each developmental step and biological function regulated by Ikaros is dependent on the proper regulation of only a small number of genes that are targets of Ikaros.
RESULTS

Generation of mutant mouse strains
We generated mice lacking Ikaros zinc-finger 1 (Ikzf1 ∆F1/∆F1 ) or zincfinger 4 (Ikzf1 ∆F4/∆F4 ) by germline deletion of exon 4 or exon 6, respectively ( Supplementary Fig. 1a ). Each deletion generated a mutant protein lacking a zinc finger and a small number of adjacent residues. Exon 4 encodes 87 residues, including the 23 residues of finger 1, 63 residues preceding the finger, and one residue following the finger. Exon 6 encodes only 41 residues. The 24-residue finger 4 is preceded by four residues that constitute the linker between fingers 3 and 4; these residues closely resembles the linker consensus sequence found in most zinc-finger proteins 28 . After the finger-encoding sequence, exon 6 encodes 13 additional residues; two prolines near the end of this region may separate the DNAbinding domain from an exon 7-encoded domain.
We confirmed correct targeting of the Ikzf1 exons by Southern blot analysis, PCR (data not shown) and immunoblot analysis ( Fig. 1a) . Ikzf1 ∆F1/∆F1 thymocytes lacked the full-length Ikaros isoform (Ik-1) but expressed Ik-2, which in wild-type mice is generated by alternative splicing of pre-mRNA 2 . In the Ikzf1 ∆F4/∆F4 strain, deletion of exon 6 reduced the size of both Ik-1 and Ik-2 ( Fig. 1a) . Analysis of thymocyte mRNA by high-throughput sequencing technology (RNA-Seq) further confirmed correct targeting, as 'reads' from exons 4 and 6 were absent from the Ikzf1 ∆F1/∆F1 and Ikzf1 ∆F4/∆F4 samples, respectively ( Fig. 1b) .
Initial analysis of mutant strains
We initiated examination of the Ikzf1 ∆F1/∆F1 and Ikzf1 ∆F4/∆F4 phenotypes soon after the mice were generated but confirmed all phenotypes after backcrossing those mice onto the C57BL/6 background through nine or more generations. Efforts to backcross Ikzf1 null mice have been unsuccessful (K. Georgopoulos and S. Winandy, personal communication), presumably because the null mutation results in embryonic death on the C57BL/6 background. The successful backcrossing of the Ikzf1 ∆F1/∆F1 and Ikzf1 ∆F4/∆F4 strains provided initial evidence that neither finger 1 nor finger 4 was required for all functions of Ikaros.
Initial studies revealed that the development of CD11b + myeloid cells was unperturbed in each strain, similar to the phenotype of Ikzf1 null mice ( Fig. 1c and Supplementary Fig. 1b ). Conventional B cells were also present in the bone marrow and spleen of each mutant strain, albeit in smaller amounts than those in wild-type mice ( Fig. 1d and Supplementary Fig. 1c,d) . The presence of B cells was in contrast to the absence of all cells of the B lineage in Ikzf1 null mice. These results suggested that DNA-binding fingers 2 and 3 were sufficient for the successful progression of a fraction of hematopoietic progenitors through B cell development. Figure 1 Adult B cells are present in mice with germline deletion of Ikzf1 exons encoding zinc-finger 1 or 4. (a) Immunoblot analysis of extracts of wild-type (WT), Ikzf1 ∆F1/∆F1 and Ikzf1 ∆F4/∆F4 thymocytes; *, unidentified form of Ikaros, most probably a post-transcriptionally modified form of Ik-1 (and Ik-2 after deletion of exon 4). SNP70 serves as a loading control. (b) RNA-Seq analysis of mRNA from wild-type, Ikzf1 ∆F1/∆F1 and Ikzf1 ∆F4/∆F4 thymocytes (n = 4 mice per strain); red outlined areas indicate targeted exons 4 (Ikzf1 ∆F1/∆F1 ) and 6 (Ikzf1 ∆F4/∆F4 ). (c) Expression of CD11b by myeloid cells in bone marrow from 6-week-old wild-type mice (n = 21), Ikzf1 ∆F1/∆F1 mice (n = 10) and Ikzf1 ∆F4/∆F4 mice (n = 14). Numbers above bracketed lines indicate percent CD11b + myeloid cells (average ± s.d.). (d) CD19 + cells (left) and CD19 + B220 + cells (right) of the B lineage in the bone marrow and spleen of 6-week-old wild-type mice (n = 12-20), Ikzf1 ∆F1/∆F1 mice (n = 9-18) and Ikzf1 ∆F4/∆F4 mice (n = 6-17), presented as total cells (left and middle) and frequency of live cells (right CD11b Events (% of max) 0 10 1 10 2 10 3 10 4 npg B cell development phenotypes Detailed examination of B cell development 41, 42 revealed striking differences among Ikzf1 ∆F1/∆F1 , Ikzf1 ∆F4/∆F4 and Ikzf1 null mice ( Supplementary Fig. 2 ). First, in contrast to the absence of pre-pro-B cells in Ikzf1 null mice due to a block in the maturation of lymphoidprimed multipotent progenitor cells 4 , Ikzf1 ∆F1/∆F1 and Ikzf1 ∆F4/∆F4 mice had relatively normal numbers of these cells ( Fig. 2a,b) . The B220 + CD43 + CD24 − BP-1 − population includes precursors of natural killer cells and plasmacytoid dendritic cells, in addition to pre-pro-B cells; when initially analyzed, Ikzf1 ∆F4/∆F4 mice had a lower abundance of these cells than did wild-type mice ( Fig. 2a) . However, natural killer cells (NK1.1 + ) and plasmacytoid dendritic cells (Ly6C + ) were selectively absent from Ikzf1 ∆F4/∆F4 mice (similar to their absence in Ikzf1 null mice), with only slightly reduced numbers of pre-pro-B cells ( Fig. 2a,b ). Both Ikzf1 ∆F1/∆F1 and Ikzf1 ∆F4/∆F4 mice also had relatively normal percentages and numbers of pro-B cells and pre-BI cells ( Fig. 2a,b) .
In contrast to the similar numbers of early progenitor cells in the two strains, Ikzf1 ∆F1/∆F1 mice had substantially decreased numbers of large pre-BII cells, yet Ikzf1 ∆F4/∆F4 mice had increased numbers of these cells, relative to their abundance in wild-type mice ( Fig. 2a,b) . Staining for cytoplasmic immunoglobulin-µ, which is expressed in most large pre-BII cells, confirmed the developmental block in Ikzf1 ∆F1/∆F1 mice, as only a small number of B220 + cells that lacked surface expression of immunoglobulin M (IgM − ) but expressed cytoplasmic immunoglobulin-µ were present ( Fig. 2c,d) . Notably, an essential role for Ikaros at this developmental stage has been suggested 7 .
Consistent with the deficiency in large pre-BII cells in Ikzf1 ∆F1/∆F1 mice, we observed considerably fewer small pre-BII cells, immature B cells and mature recirculating B cells in these mice than in wildtype mice ( Fig. 2a,b) . In Ikzf1 ∆F4/∆F4 mice, the number of cells in these populations was reduced to a lesser degree ( Fig. 2a,b) . Notably, although much of B cell development seemed to be largely intact in Ikzf1 ∆F4/∆F4 mice, c-Kit + early progenitor cells with low to negative expression of lineage markers (Lin neg-lo ) had lower expression of the receptor tyrosine kinase Flt3 and of interleukin 7 receptor α-chain (IL-7Rα) than did their wild-type counterparts ( Fig. 2e,f) . This phenotype was reminiscent of that of Ikzf1 null mice, although in the Ikzf1 ∆F4/∆F4 mice, expression of these proteins apparently was not reduced to a sufficient extent to block development.
Additional finger-specific functions in hematopoiesis
The developmental abnormalities of T cells were far more severe in Ikzf1 ∆F4/∆F4 mice than in Ikzf1 ∆F1/∆F1 mice. Both strains exhibited slightly reduced thymic cellularity, with a greater reduction in Ikzf1 ∆F4/∆F4 mice, relative to that of their wild-type littermates ( Fig. 3a) . During the CD4 − CD8 − double-negative stages 1-4 (DN1-DN4) of thymopoiesis, reduced cell numbers were readily apparent in Ikzf1 ∆F4/∆F4 mice but not in Ikzf1 ∆F1/∆F1 mice, relative to their abundance in wild-type mice ( Fig. 3b and Supplementary Fig. 3a-d) . The DN1 population (CD44 + CD25 − ) 43 seemed to be smaller in Ikzf1 ∆F1/∆F1 mice than in wild-type mice ( Fig. 3b and Supplementary  Fig. 3a ). However, that reduction was due to greatly reduced numbers of other cell types that contaminated the DN1 population, including thymic B cells (discussed below). Consistent with that interpretation, the percentage of early thymic progenitor cells was normal in Ikzf1 ∆F1/∆F1 mice but reduced in Ikzf1 ∆F4/∆F4 mice (Fig. 3c) . The frequency of DN2 (CD44 + CD25 + ) and DN3 (CD44 − CD25 + ) cells was also greatly reduced in Ikzf1 ∆F4/∆F4 mice but normal in Ikzf1 ∆F1/∆F1 mice, relative to their abundance in wild-type mice ( Fig. 3b and Supplementary Fig. 3b,c) . DN4 cells (CD44 − CD25 − ) recovered in the Ikzf1 ∆F4/∆F4 strain to percentages and numbers similar to those observed in wild-type mice, presumably by homeostatic proliferation ( Fig. 3b and Supplementary Fig. 3d ). The ratio of CD4 + CD8 + double-positive (DP) thymocytes to CD4 + or CD8 + single-positive (SP) thymocytes in Ikzf1 ∆F1/∆F1 mice was similar to that of wild-type mice but was significantly reduced in Ikzf1 ∆F4/∆F4 mice ( Fig. 3d and Supplementary Fig. 3e ). The reduced number of DP thymocytes in Ikzf1 ∆F4/∆F4 mice correlated with a reduction in the size of the thymic cortex ( Fig. 3e) . Neither Ikzf1 ∆F1/∆F1 nor Ikzf1 ∆F4/∆F4 mice exhibited the extreme skewing toward the CD4 + lineage that characterizes Ikzf1 null mice 1 ( Fig. 3d and Supplementary Fig. 3f ).
Ikzf1 null mice have reduced numbers of thymic γδ T cells 1 . These cells were largely unperturbed in number in Ikzf1 ∆F1/∆F1 mice and increased in number in Ikzf1 ∆F4/∆F4 mice, relative to their abundance in wild-type mice ( Fig. 3f ). Thymocyte analysis also revealed a severe reduction in the number of thymic B cells (CD19 + CD4 − CD8 − ) in Ikzf1 ∆F1/∆F1 mice relative to that of wild-type mice (Fig. 3g) . This selective and consistent phenotype is difficult to explain, given the similar number of conventional B-2 cells in the spleen of the two mutant strains. Furthermore, examination of the peritoneal cavity revealed reduced numbers of the B-1a population in each mutant strain and a reduced number of B-1b cells only in the Ikzf1 ∆F1/∆F1 strain, relative to that of wild-type mice ( Supplementary Fig. 3g,h) . Further analysis of these phenotypes may provide insight into the developmental origin, homing mechanism and/or function of thymic B cells and peritoneal B-1 cells. Although adult mutant mice had substantial numbers of mature B cells and T cells, the Ikzf1 ∆F4/∆F4 strain lacked cells of both the B lineage and T lineage in the fetus (Fig. 3h-j and Supplementary  Fig. 4a-c) . In contrast, fetal T cell numbers were normal and fetal B cells were only moderately reduced in the Ikzf1 ∆F1/∆F1 strain ( Fig. 3h-j and Supplementary Fig. 4a-c) . Lymphoid tissue-inducer cells (CD45 + CD3ε − CD4 + IL-7Rα + ) were also selectively absent from the fetal intestinal mesentery of Ikzf1 ∆F4/∆F4 mice (Fig. 3k) . This phenotype correlated with the selective absence of lymph nodes (inguinal and lumbar) and Peyer's patches in adult Ikzf1 ∆F4/∆F4 mice ( Fig. 3l and Supplementary Fig. 4d ), consistent with the important role of fetal lymphoid tissue-inducer cells in the development of these lymphoid structures 1, 44 . Nasal-associated lymphoid tissue, which develops postnatally 44 , was intact ( Supplementary Fig. 4e ). These developmental defects were reminiscent of those described for Ikzf1 null mice 1 , which suggested that zinc-finger 4 was required for the proper regulation of genes encoding molecules involved in early stages of fetal lymphopoiesis. Notably, zinc-finger 1 and all other residues encoded by exon 4 seemed to be dispensable for these developmental events.
Finger-specific DNA binding in vivo
The generation of the Ikzf1 ∆F1/∆F1 and Ikzf1 ∆F4/∆F4 strains was inspired by evidence that fingers 1 and 4 support the binding to different DNA sequences in vitro [29] [30] [31] . To determine whether the two fingers also participated in binding to different DNA sequences in vivo, we used ChIPseq analysis of total thymocytes from 4-week-old wild-type, Ikzf1 ∆F1/∆F1 and Ikzf1 ∆F4/∆F4 mice. The most prominent ChIP-seq peaks were present at simple repetitive elements that contained multiple copies of the core Ikaros consensus sequence of GGGAA ( Fig. 4a-d) . Some of these simple repeats were located in close proximity to protein-encoding genes, but these repeats have not been conserved through evolution and therefore may not have important functions. Nevertheless, the ChIPseq profiles confirmed that fingers 1 and 4 contributed to differences in DNA binding in vivo. For example, a repeat region in Snx29 (which encodes a sorting nexin) exhibited a prominent ChIP-seq peak in wildtype thymocytes and in thymocytes from both mutant strains (Fig. 4a) , which suggested that fingers 2 and 3 were sufficient for binding to this region. In contrast, a prominent ChIP-seq peak in Nr3c2 (which encodes the mineralocorticoid receptor Mlr) was present in wild-type and Ikzf1 ∆F4/∆F4 thymocytes but not in Ikzf1 ∆F1/∆F1 thymocytes (Fig. 4b) .
At a repeat region adjacent to Snx25 (which encodes a sorting nexin) (Fig. 4d) , and at a repeat in chromosome 19 that is not linked to an annotated gene (Fig. 4c) , ChIP-seq peaks were present in wild-type and Ikzf1 ∆F1/∆F1 thymocytes but not in Ikzf1 ∆F4/∆F4 thymocytes.
Inspection of the repeats revealed regions containing the Ikaros consensus sequence GGGAA but with different flanking nucleotides. Motif analysis of these regions in Snx29 and Nr3c2 revealed two repetitive sequences that may support the binding of Ikaros, while one repetitive sequence that may support the binding of Ikaros was present in the regions in Snx25 and chromosome 19 (Fig. 4) . In vitro bindingsite-selection experiments have suggested that finger 1 recognizes a pyrimidine-rich sequence downstream of the Ikaros core 29 (S.E.W. and S.T.S., data not shown). On the basis of those studies, finger 1 would be predicted to bind the TCC sequence in one of the Nr3c2 repeats (Fig. 4b,  bottom right) . The other Nr3c2 consensus (Fig. 4b, bottom left) and the two Snx29 consensus sequences (Fig. 4a ) may also contact finger 1, but perhaps more weakly because the nucleotides that would be contacted by finger 1 include a purine. In contrast, we predict that the repeats in Snx25 and chromosome 19 (Fig. 4c,d) have little ability to interact with finger 1 because the GGGAA core is followed by purine residues. 
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The binding site-selection data 29 and additional findings (S.E.W. and S.T.S., data not shown) failed to reveal a strong DNA sequence 'preference' for finger 4. Instead, finger 4 seemed to stabilize binding in a DNA sequence-independent manner, with its DNA contacts particularly important at sites not stably bound by fingers 2 and 3 alone (S.E.W. and S.T.S., data not shown). We hypothesize that finger 4 may be important for the repeats in Snx25 and chromosome 19 because the DNA-binding energy of fingers 2 and 3 is weakened by the presence of a purine just downstream of the GGGAA core; we have found that a pyrimidine at this position is important for stable protein-DNA interactions by fingers 2 and 3 (S.E.W. and S.T.S., data not shown).
To determine whether the difference in binding observed by ChIPseq was due to intrinsic DNA-binding 'preferences' , we did electrophoretic mobility-shift assays (EMSAs) with recombinant proteins containing different combinations of zinc fingers. Consistent with the ChIP-seq results, we observed substantial binding to one of the Snx29 sequences with a protein containing all four fingers, as well as with proteins containing only fingers 1-3 or 2-4 ( Fig. 4e) . The second Snx29 repeat (with a GaGAA core instead of the GGGAA core, where the lowercase 'a' indicates the difference from the consensus core sequence) was unable to bind any of the proteins (Supplementary Fig. 5a ). We observed substantial binding to one of the Nr3c2 sequences with proteins containing fingers 1-4 or 1-3 but not with a protein containing fingers 2-4 ( Fig. 4e) , which demonstrated finger 1-dependent binding. Finally, we observed substantial binding to the Snx25 repetitive sequence with proteins containing fingers 1-4 or fingers 2-4 but not with a protein containing fingers 1-3 (Fig. 4e) . Thus, the intrinsic in vitro binding capacity mirrored the in vivo ChIP-seq results.
In addition to identifying the prominent interactions noted above (Fig. 4) , the ChIP-seq results revealed thousands of other Ikarosbinding sites throughout the genome. More than 60% of the ChIP-seq peaks coincided with the Ikaros core sequence of GGGAA ( Fig. 4f  and Supplementary Fig. 5b) . In experiments with wild-type or mutant thymocytes, the number of 'called peaks' varied from about 1,000 to 17,000. Those numbers are in the same range as the 7,000 Ikaros peaks in thymocytes reported before 16 , with extensive overlap observed between the peaks in our experiments and those reported before. Zfp64, Zfp260, Cd4, Notch1, Hdac7, and Bcl11b are examples of genes exhibiting the same Ikaros peaks in our experiments and in published reports 16, 18, 19 (Supplementary Fig. 5c ). Motif-enrichment analysis revealed that the core Ikaros recognition sequence of GGGAA was highly prevalent at peaks that overlapped in the wild-type data set and in the data sets from both mutant strains (Supplementary Fig. 5d ). Furthermore, the sequence GGGAAAAGGGAA was prevalent at peaks selectively absent from the Ikzf1 ∆F4/∆F4 sample ( Supplementary  Fig. 5d ). That sequence is very similar to the sequences noted above (Fig. 4c,d ) that exhibited finger 4 dependence, which suggested that finger 4 would be broadly important for binding to such sequences throughout the genome. Thus, the ChIP-seq data supported a model in which the different functions of fingers 1 and 4 are due at least in part to their ability to facilitate binding to distinct genomic sites (discussed below).
Selective misregulation of gene expression
Although thousands of Ikaros-binding sites were identified by ChIP-seq, the highly selective phenotypes of the Ikzf1 ∆F1/∆F1 and Ikzf1 ∆F4/∆F4 strains suggested that DNA-binding fingers 1 and 4 may contribute to the regulation of distinct sets of genes. To examine the roles of fingers 1 and 4 in transcriptional control, we obtained mRNA from CD4 + CD8 + thymocytes sorted from 4-week-old wild-type, Ikzf1 ∆F1/∆F1 , and Ikzf1 ∆F4/∆F4 mice and analyzed the mRNA by RNA-Seq. The results revealed misregulation of small number of genes in each of the mutant strains, relative to their expression in wild-type mice. In Ikzf1 ∆F4/∆F4 thymocytes, only 110 genes and 12 genes (with RPKM (reads per kilobase per million mapped reads) values of ≥4) were upregulated and downregulated, respectively, by more than threefold, with only 24 and 21 genes upregulated and downregulated, respectively, by this magnitude in Ikzf1 ∆F1/∆F1 thymocytes ( Fig. 5a  and Supplementary Fig. 6 ). Notably, only 15 genes were upregulated in both mutant strains and 1 gene was downregulated in both strains. Three genes upregulated in Ikzf1 ∆F4/∆F4 thymocytes were downregulated in Ikzf1 ∆F1/∆F1 thymocytes. Notably, much smaller numbers of genes were upregulated or downregulated by tenfold or more ( Fig. 5b  and Supplementary Fig. 6) . Although it is difficult to accurately compare RNA-Seq data sets to microarray data sets, many of the genes found by RNA-Seq to be misregulated in Ikzf1 ∆F1/∆F1 or Ikzf1 ∆F4/∆F4 thymocytes have been found by microarray to be misregulated in Ikzf1 null thymocytes 16 . Thus, misregulated genes in Ikzf1 null thymocytes seem to represent a composite of the genes misregulated in Ikzf1 ∆F1/∆F1 and Ikzf1 ∆F4/∆F4 thymocytes. Gene-ontology analysis of genes upregulated threefold or more in Ikzf1 ∆F4/∆F4 thymocytes revealed enrichment for genes encoding molecules involved in cell adhesion, cell communication and signal transduction (Fig. 5c) . Consistent with the invasive properties of the thymic lymphomas that arose in older Ikzf1 ∆F4/∆F4 mice (reported below), several genes encoding molecules involved in tumor invasion and metastasis were among the genes upregulated the most, including Mmp14 (which encodes a matrix metalloprotease), Ctnnd1 (which encodes δ-catenin) and Dock1 (which encodes a guanine nucleotide-exchange factor) [45] [46] [47] [48] (Supplementary Fig. 6e,g) .
Notably, genes that were upregulated in either Ikzf1 ∆F1/∆F1 or Ikzf1 ∆F4/∆F4 thymocytes generally had very low expression in wildtype thymocytes (Fig. 5d) . We assessed the distribution by the expression (RPKM) in thymocytes of all annotated genes and the RPKM distribution in wild-type cells of genes upregulated by at least threefold in Ikzf1 ∆F1/∆F1 or Ikzf1 ∆F4/∆F4 thymocytes (Fig. 5d) . As the vast majority (>96%) of upregulated genes were upregulated from very low expression (RPKM < 5), these results were consistent with evidence that Ikaros often functions as a transcriptional repressor.
Zinc-finger requirements for tumor suppression
Published Ikaros-mutant strains develop thymic lymphoma 10, 11 . We never observed lymphoma in Ikzf1 ∆F1/∆F1 mice, but Ikzf1 ∆F4/∆F4 mice developed thymic lymphoma with a penetrance similar to that reported for other Ikaros-mutant strains (Fig. 6a) . Also similar to other Ikaros-mutant strains, the lymphomas in Ikzf1 ∆F4/∆F4 mice were aggressive (highly invasive and metastatic) (Fig. 6b,c) and they displayed variable expression of the coreceptors CD4 and CD8 (Fig. 6d) , clonal rearrangement of the gene encoding the T cell antigen receptor β-chain, and aberrant expression of the intracellular domain of the signaling receptor Notch (data not shown).
Ikzf1 mutations in a mouse model of BCR-ABL + B-ALL
Although Ikzf1 mutations invariably give rise to T cell malignancies in mice, human malignancies of T cell origin rarely have IKZF1 mutations 49 . Instead, human IKZF1 mutations are frequently associated with BCR-ABL + B-ALL and other progenitor-B cell malignances 12, 13 . To investigate this species difference, and with the additional goal of developing models with which to study progenitor-B cell malignancies associated with IKZF1 mutations, we first made use of a well-established in vitro culture assay for BCR-ABL + B-ALL 50 . We obtained bone marrow cells from wild-type, Ikzf1 ∆F1/∆F1 and Ikzf1 ∆F4/∆F4 mice and transduced those cells with a retrovirus expressing the oncogenic tyrosine kinase BCR-ABL, then monitored cell numbers in the progenitor B cell cultures over the course of approximately 3 weeks. Transduced Ikzf1 ∆F4/∆F4 cells proliferated much more rapidly than did their wild-type counterparts (Fig. 7a) . Notably, transduced Ikzf1 ∆F1/∆F1 cells proliferated more slowly than did their wild-type counterparts and eventually stopped growing ( Fig. 7a and data not shown) .
We next used an in vivo model of BCR-ABL + B-ALL in which we transplanted bone marrow cells transduced with the retrovirus expressing BCR-ABL into irradiated wild-type C57BL/6 recipient mice. In this assay, transduced Ikzf1 ∆F4/∆F4 cells yielded much more aggressive malignancies than did their wild-type or Ikzf1 ∆F1/∆F1 counterparts (Fig. 7b) . These results demonstrated that an Ikzf1 mutation was able to contribute to B cell malignancy in mice when combined with BCR-ABL expression. Furthermore, these results established an important parallel between the tumor-suppressor function of Ikaros in thymocytes and progenitor cells-B cells; in both cell types, finger 4 was essential for tumor suppression, whereas finger 1 was dispensable.
To approach an understanding of the tumor-suppressor function of Ikaros, we transduced cells with retrovirus expressing BCR-ABL, obtained mRNA from the cells after 21 or 28 d of culture and analyzed the mRNA by RNA-Seq. We also analyzed sorted pro-B cells and pre-BI cells plus large pre-BII cells, which are thought to most closely represent the developmental stages that expand following BCR-ABL transformation. Cluster analysis revealed extensive differences between the normal cells and transformed cells in their gene expression ( Fig. 7c) . However, most of the changes in gene expression were unaffected by the Ikzf1 mutations. Clusters 1-3, for example, showed differences between all of the data sets from untransformed cells and all of the data sets from transformed cells (Fig. 7c) . Gene-ontology analysis of the two largest clusters (1 and 2) revealed, as expected, that several genes encoding molecules involved in the cell cycle and control of cell growth were upregulated after transformation with BCR-ABL, whereas genes encoding molecules involved in leukocyte differentiation and activation were downregulated (Supplementary Fig. 7) . Figure 6 Ikzf1 ∆F4/∆F4 mice develop spontaneous thymic lymphoma but Ikzf1 ∆F1/∆F1 mice do not. (a) Survival of wild-type, Ikzf1 ∆F1/+ and Ikzf1 ∆F1/∆F1 mice (left) and wild-type, Ikzf1 ∆F4/+ and Ikzf1 ∆F4/∆F4 mice (right), presented as Kaplan-Meier curves. (b) Histochemical analysis of hematoxylin-and eosin-stained heart tissue from an Ikzf1 ∆F4/∆F4 mouse (right; n = 3) and a wild-type control mouse (left), showing a thymic lymphoma at right. (c) Histochemical analysis of hematoxylin-and eosin-stained lung tissue from an Ikzf1 ∆F4/∆F4 mouse (right) and a wild-type mouse (left), showing an infiltrating thymic lymphoma at right. (d) Expression of CD4 and CD8 in lymphomas that had metastasized to the spleen in Ikzf1 ∆F4/∆F4 mice (n = 3) and a wild-type mouse (control). Data are from one experiment with a large cohort of mice (a) or with one representative mouse of three or more mice (b-d). npg 1 0 8 0 VOLUME 14 NUMBER 10 OCTOBER 2013 nature immunology A r t i c l e s The remaining three clusters (4-6) included genes with higher expression in BCR-ABLtransformed Ikzf1 ∆F1/∆F1 cells than in their wild-type or Ikzf1 ∆F4/∆F4 counterparts (Fig. 7c) . Those same genes also had higher expression in untransformed Ikzf1 ∆F1/∆F1 pre-BI cells plus large pre-BII cells (Fig. 7c) , which suggested that the Ikzf1 ∆F1/∆F1 cells that proliferated in culture following BCR-ABL transformation were maintained at the pre-BI cell-to-large pre-BII cell developmental stage, a stage at which many genes were misregulated in Ikzf1 ∆F1/∆F1 mice. Notably, most genes in all six clusters had similar expression in wild-type and Ikzf1 ∆F4/∆F4 cells (Fig. 7c) , despite the greatly enhanced proliferation of BCR-ABL-transformed Ikzf1 ∆F4/∆F4 cells.
To identify genes selectively misregulated in BCR-ABL-transformed Ikzf1 ∆F4/∆F4 cells, we did an additional cluster analysis with the six data sets obtained with transformed cells; we then aligned the expression of the respective genes in untransformed cells after we defined the clusters. This analysis revealed 155 genes that were selectively upregulated and 133 genes that were selectively downregulated in Ikzf1 ∆F4/∆F4 cultures relative to their expression in wild-type and Ikzf1 ∆F1/∆F1 cultures, at both day 21 and day 28 (Fig. 7d) . Among the genes with higher expression in Ikzf1 ∆F4/∆F4 cells was Kit (which encodes the stem cell factor receptor c-Kit) ( Fig. 7d-f) , which is known to be silenced during B cell maturation. Among the genes with lower expression were Il2ra (which encodes the IL-2 receptor α-chain CD25) and Enpep (which encodes the cell surface marker BP-1), which are activated during B cell maturation ( Fig. 7d-f) . Flow cytometry confirmed misregulation of the proteins encoded by Kit (c-Kit) and Il2ra (CD25) (Fig. 7e) .
These findings suggested that the Ikzf1 ∆F4/∆F4 mutation may influence the developmental stage of cells transformed by BCR-ABL. However, most of the other genes that were selectively misregulated in BCR-ABL-transformed Ikzf1 ∆F4/∆F4 cells are not developmentally regulated, and several, such as Dock1 and Ctnnd1, correspond to genes that were also misregulated in Ikzf1 ∆F4/∆F4 thymocytes. This identification of a limited set of genes selectively misregulated in transformed cells in the context of the Ikzf1 ∆F4/∆F4 mutation provides an important step toward delineating the elusive mechanisms responsible for the tumorsuppressor function of Ikaros.
DISCUSSION
We have created two new mouse strains in which exons encoding individual zinc fingers of Ikaros were deleted. Our results have demonstrated that different zinc fingers in a single DNA-binding domain can participate in the regulation of distinct sets of genes and contribute to distinct biological functions. The disruption of individual fingers may be a generally valuable strategy for delineating the complex biological functions and mechanisms of action of zinc-finger transcription factors.
When designing the mutant strains, we considered three different strategies: deletion of the exons encoding fingers 1 and 4; 
Il2ra
Enpep deletion of DNA sequences encoding fingers 1 and 4, with retention of the remaining sequences of exons 4 and 6; or mutagenesis of specific nucleotides encoding key residues of fingers 1 and 4 involved in DNA binding. Each strategy had notable advantages and limitations. An advantage of the second and third strategies is that it would be possible to exclude the possibility of involvement of non-finger residues in the resulting phenotypes. However, a major limitation of those strategies is that the mutant proteins do not normally exist in mouse cells, which would raise the possibility of dominant-negative or gain-of-function activities. Consistent with that, a point mutation in the Ikzf1 region encoding finger 3 has been found to have much stronger dominant-negative properties in mice than a deletion mutant that results in complete removal of exons encoding fingers 1, 2 and 3 (ref. 51 ). Furthermore, preliminary data have suggested that exon 4-encoded residues immediately upstream of finger 1 autoregulate the DNA-binding activity of finger 1 (S.E.W. and S.T.S., data not shown); retention of those residues with deletion of finger 1 would have an uncertain outcome. Because of the limitations noted above, we deleted exons 4 and 6, which encode fingers 1 and 4, respectively, as well as the small number of additional residues encoded by these exons. With this strategy, it remains possible that some of the hematological defects are due to the loss of activities other than the DNA-binding activity of the deleted finger. However, we were able to conclude with confidence that finger 1 and finger 4 were fully and differently dispensable for several biological functions of Ikaros, and our data suggested that at least a subset of the defects of each strain was due to loss of finger-dependent DNA interactions. Furthermore, the Ikzf1 ∆F1/∆F1 strain revealed the specific functions of full-length Ikaros (Ik-1), as this strain lacked the Ik-1 isoform while retaining the naturally occurring Ik-2 isoform. Moreover, since the long-term goal is to delineate the highly selective phenotypes of the mutant strains for the purpose of understanding how Ikaros regulates lymphopoiesis and leukemogenesis, we can proceed with relatively little concern about the possibility of aberrant gain-of-function activities.
We unexpectedly found that the two fingers regulated different biological functions and even different steps in the same developmental pathway. We originally anticipated that Ikaros would regulate numerous genes involved in each developmental step in which it participates, such that each mutant strain would exhibit phenotypes similar to that of Ikzf1 null mice. That expectation was based on evidence that gene expression is substantially altered in Ikzf1 null cells 16, 20 and that Ikaros binds to several thousand genomic sites, as shown by ChIP-seq experiments 16 . Instead, we found that finger 1 was largely or fully dispensable for many biological functions of Ikaros, with finger 4 being dispensable for several other functions.
That selectivity provides support for a hypothesis in which only one target gene or a small number of target genes is (are) essential for each biological event in which Ikaros participates. It is difficult to envision that Ikaros would be a critical regulator of hundreds of genes required for each biological event, with finger 1 being dispensable for the regulation of all target genes involved in some events and finger 4 being dispensable for the regulation of all genes involved in other events. Instead, it seems much more likely that each event requires the proper regulation of only one or a few genes that are targets of Ikaros, with either finger 1 or finger 4 being critical for the regulation of those genes. Although we favor a model in which Ikaros is an essential regulator of only a few key genes involved in each biological event, an alternative possibility is that fingers 2 and 3 are sufficient for the regulation of almost all critical target genes involved in each of its biological functions, with fingers 1 or 4 essential for the regulation of only a few key genes.
A longstanding challenge in the transcription field has been the identification of direct targets of transcription factors that can explain their biological functions. Efforts to identify such targets have benefited from the development of gene-expression profiling methods and methods for examining DNA binding in vivo on a genome-wide scale (such as ChIP-seq). By merging ChIP-seq data with the geneexpression profiles of wild-type and mutant cells, insights into the direct targets of a transcription factor can be obtained. However, a major limitation of this approach is that many transcription factors may bind genomic sites at which they do not function 52 . Moreover, because some transcription factors may 'preferentially' bind sequences associated with the relatively open chromatin found at active promoters and enhancers, it can be difficult to conclude with confidence that the merging of gene-expression and ChIP data sets has successfully identified the direct functional targets.
In our RNA-Seq studies, we found that most misregulated genes in Ikzf1 ∆F1/∆F1 and Ikzf1 ∆F4/∆F4 thymocytes had low expression in wildtype cells, whereas Ikaros-binding sites defined by ChIP-seq were distributed among genes at all levels of expression (data not shown). Furthermore, the number of ChIP-seq peaks greatly exceeded the number of misregulated genes. One possible and perhaps likely interpretation of these results is that most Ikaros-binding sites identified by ChIP-seq are not functionally relevant. However, many other possibilities must be considered. For example, Ikaros may contribute to the proper regulation of a much larger number of genes, but its absence may alter the level of expression of most target genes by a magnitude that fails to reach the threefold cutoff used for our analyses. Another possibility is that Ikaros acts redundantly with other members of the Ikaros family at many of its target genes.
We originally were hopeful that ChIP-seq analysis of our mutant strains would reveal a distinct loss of Ikaros binding to a welldefined subset of sites, which would lead to improved correlation between binding and transcriptional misregulation of nearby genes. However, although we observed reduced numbers of ChIP-seq peaks for Ikzf1 ∆F1/∆F1 and Ikzf1 ∆F4/∆F4 thymocytes (data not shown), we have been unable to do a meaningful analysis of the binding events that require or are enhanced by these fingers. A chief reason for this difficulty is that the ChIP-seq peaks were not clearly polarized, in that we did not observe a distinct subset of peaks that were entirely dependent on finger 4 and another subset of peaks that were entirely dependent on finger 1. Instead, we observed a continuum of effects, with different yet highly variable degrees of dependence on finger 1 or finger 4.
The potential value of targeting individual zinc fingers can be summarized as follows. First, the Ikzf1 ∆F1/∆F1 and Ikzf1 ∆F4/∆F4 mice exhibited select subsets of the hematopoietic defects of Ikzf1 null mice. Second, when we observed a phenotype, it was as robust or nearly as robust as that of Ikzf1 null mice, which makes the phenotype amenable to further analysis. Third, despite the robust phenotypes, geneexpression changes were quite limited, which narrowed the list of potential direct and indirect target genes responsible for the phenotype. These findings pave the way for detailed analyses of each phenotype of the mutant strains.
Our results raise the question of why Ikaros and perhaps other zincfinger transcription factors acquired the ability to bind DNA through different subsets of their fingers. One possibility is that this strategy allows Ikaros to recognize a larger number of DNA sequences, so that each target gene does not need to have a sequence that matches a single, rigid consensus. Although that simple scenario is possible, we favor a model in which recognition of DNA through different combinations of fingers supports different functions. One possibility npg 1 0 8 2 VOLUME 14 NUMBER 10 OCTOBER 2013 nature immunology A r t i c l e s is that binding to DNA through different combinations of zinc fingers leads to conformational differences in the bound protein that may influence coregulatory interactions. The zinc-finger DNA-binding protein CTCF has similarly been suggested to carry out different functions when bound to DNA through different subsets of its fingers 40 , yet this hypothesis has not yet been tested through the disruption of individual CTCF fingers.
Finally, it can be argued that the most important function of Ikaros to understand is its tumor-suppressor function. The correlation between IKZF1 mutations and the therapeutic response of high-risk progenitor B-ALL suggests that understanding of the tumorsuppressor function of Ikaros may be critical for the development of new therapies 12, 13 . The establishment of a mouse model for BCR-ABL + B-ALL through the use the Ikzf1 ∆F4/∆F4 strain confirms a published report that B cell malignancies can be observed in an Ikaros-mutant strain when coupled to BCR-ABL expression 53 . The finding that finger 4 was selectively required for tumor suppression both in thymocytes and in the BCR-ABL + B-ALL model suggests that tumor suppression in the two cell types may involve similar molecular mechanisms. That hypothesis is further supported by the finding that many of the same genes were misregulated in Ikzf1 ∆F4/∆F4 thymocytes and in BCR-ABL-transformed progenitor B cells from Ikzf1 ∆F4/∆F4 mice. The loss of the tumor-suppressor function of Ikaros in the Ikzf1 ∆F4/∆F4 strain will make this strain particularly valuable for future studies, as it exhibits only a subset of the hematopoietic defects of Ikzf1 null mice. This feature will allow studies of the tumor-suppressor function on a background in which many target genes of Ikaros involved in its other functions are relatively unperturbed.
METHODS
Methods and any associated references are available in the online version of the paper.
